Investors aren't happy about the COVID-19 resurgence.
News & Analysis: TrueCar
One is developing a COVID-19 vaccine; the other two are from rebounding industries.
A key analyst gave it an optimistic upgrade. Is he right?
TRUE earnings call for the period ending March 31, 2020.
An earnings miss and no guidance aren't helping the stock.
The company moved quickly to respond to the COVID-19 outbreak.
TrueCar puts most of the car-buying experience online -- and that seems attractive right now.
Socially-distant car shopping? TrueCar can help.
Auto investors hoping for a quick rebound will be disappointed.
March sales numbers are coming in, and they're grim.